Crescent Biopharma, Inc. (CBIO) Covered Calls

Crescent Biopharma, Inc. covered calls Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing novel medicines to address serious medical conditions.

There are no covered calls available for Crescent Biopharma, Inc..

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Catalyst Biosciences, Inc. Formerly known as Targacept, Inc.. The Company's principal activity is to design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the central nervous system by selectively targeting a class of receptors known as neuronal nicotinic receptors. It is developing an advanced product candidates as treatments for target indications in three therapeutic areas: cognitive impairment, depression and anxiety, and pain. The products of the Company include TC-1734 as a treatment for Alzheimer's disease, cognitive deficits in schizophrenia and potentially other conditions marked by cognitive impairment. Mecamylamine hydrochloride is the active ingredient in Inversine. Inversine is approved for the management of moderately severe to severe essential hypertension, a high blood pressure disorder.